Chronic pain management in the cancer survivor: Tips for primary care providers

Nurse Practitioner

Volumn 38, Issue 6, 2013, Pages 28-38

  Davies, Pamela Stitzlein ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Cancer survivor; Chronic cancer related pain; Primary care

Indexed keywords

ANXIETY; ARTICLE; CASE REPORT; CHRONIC PAIN; FEMALE; HUMAN; MENTAL STRESS; METHODOLOGY; MIDDLE AGED; NEOPLASM; NURSING; NURSING METHODOLOGY RESEARCH; PRIMARY HEALTH CARE; PSYCHOLOGICAL ASPECT; SURVIVOR;

ANXIETY; CHRONIC PAIN; FEMALE; HUMANS; MIDDLE AGED; NEOPLASMS; NURSING METHODOLOGY RESEARCH; PRIMARY CARE NURSING; STRESS, PSYCHOLOGICAL; SURVIVORS;

EID: 84879157830     PISSN: 03611817     EISSN: 15388662     Source Type: Journal    
DOI: 10.1097/01.NPR.0000429893.95631.63     Document Type: Article

References (53)

1. Siegel R, DeSantis C, Virgo K, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012;62(4):220-241.
2. van den Beuken-van Everdingen M. Chronic pain in cancer survivors: a growing issue. J Pain Palliat Care Pharmacother. 2012;26(4):385-387.
3. Burton AW, Fanciullo GJ, Beasley RD, Fisch MJ. Chronic pain in the cancer survivor: a new frontier. Pain Med. 2007;8(2):189-198.
4. American Society of Clinical Oncology. 2008-2013 Workforce Strategic Plan to Ensure Continuing Access to Quality Cancer Care. 2008. http://www.asco. org/advocacy-practice/workforce-initiatives.
5. Hudson SV, Miller SM, Hemler J, et al. Adult cancer survivors discuss followup in primary care:'not what I want, but maybe what I need'. Ann Fam Med. 2012;10(5):418-427.
6. Burstein HJ, Winer EP. Primary care for survivors of breast cancer. N Engl J Med. 2000;343(15):1086-1094.
7. Office of Cancer Survivorship. Survivorship Definitions. 2011. http://dccps. nci.nih.gov/ocs/definitions.html.
8. Feuerstein M. Defining cancer survivorship. J Cancer Surviv. 2007;1(1):5-7.
9. Polomano R, Ashburn M, Farrar J. Pain syndromes in cancer survivors. In: Bruera ED, Portenoy, RK, eds. Cancer Pain: Assessment and Management. 2nd ed. New York: Cambridge University Press; 2010:145-163.
10. Harrington CB, Hansen JA, Moskowitz M, Todd BL, Feuerstein M. It's not over when it's over: long-term symptoms in cancer survivors-a systematic review. Int J Psychiatry Med. 2010;40(2):163-181.
11. Hewitt ME, Greenfield S, Stovall E. From Cancer Patient to Cancer Survivor: Lost in Transition. National Academy Press; 2006.
12. Mao JJ, Armstrong K, Bowman MA, Xie SX, Kadakia R, Farrar JT. Symptom burden among cancer survivors: impact of age and comorbidity. J Am Board Fam Med. 2007;20(5):434-443.
13. Sun V, Borneman T, Piper B, Koczywas M, Ferrell B. Barriers to pain assessment and management in cancer survivorship. J Cancer Surviv. 2008;2(1):65-71.
14. Chou R, Qaseem A, Snow V, et al. Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society. Ann Intern Med. 2007;147(7):478-491.
15. Prasad D, Schiff D. Malignant spinal-cord compression. Lancet Oncol. 2005;6(1):15-24.
16. Cole JS, Patchell RA. Metastatic epidural spinal cord compression. Lancet Neurol. 2008;7(5):459-466.
17. Fitzgibbon DR, Loeser JD. Cancer Pain: Assessment, Diagnosis, and Management. Lippincott Williams & Wilkins; 2010.
18. American Cancer Society. Signs and symptoms of cancer. 2012. http://www.cancer.org/cancer/cancerbasics/signs-and-symptoms-of-cancer.
19. Pasero C, McCaffery M. Pain Assessment and Pharmacologic Management. St. Louis: Mosby; 2011.
20. Wickham R. Chemotherapy-induced peripheral neuropathy: a review and implications for oncology nursing practice. Clin J Oncol Nurs. 2007;11(3):361-376.
21. Stubblefield MD. Cancer rehabilitation. Semin Oncol. 2011;38(3):386-393.
22. Niravath P. Aromatase inhibitor-induced arthralgia: a review. Annals of Oncology. [e-pub March 6, 2013.]
23. Paice JA. Chronic treatment-related pain in cancer survivors. Pain. 2011;152(suppl 3):S84-S89.
24. Fu M, Smith J. Lymphedema management. In: Ferrell B, Coyle N, eds. Oxford Textbook of Palliative Nursing. 3rd ed. New York: Oxford University Press; 2010:341-358.
25. Dizon DS. Quality of life after breast cancer: survivorship and sexuality. Breast J. 2009;15(5):500-504.
26. Vistad I, Cvancarova M, Kristensen GB, Fosså SD. A study of chronic pelvic pain after radiotherapy in survivors of locally advanced cervical cancer. J Cancer Surviv. 2011;5(2):208-216.
27. Otis-Green S, Sherman R, Perez M, Baird RP. An integrated psychosocial -spiritual model for cancer pain management. Cancer Pract. 2002;10 (suppl 1):S58-S65.
28. Gunnarsdottir S, Donovan HS, Serlin RC, Voge C, Ward S. Patient-related barriers to pain management: the Barriers Questionnaire II (BQ-II). Pain. 2002;99(3):385-396.
29. Pachman DR, Barton DL, Swetz KM, Loprinzi CL. Troublesome symptoms in cancer survivors: fatigue, insomnia, neuropathy, and pain. J Clin Oncol. 2012;30(30):3687-3696.
30. Bruera E, Portenoy RK. Cancer Pain: Assessment and Management. Cambridge University Press; 2010.
31. Paice JA, Ferrell B. The management of cancer pain. CA Cancer J Clin. 2011;61(3):157-182.
32. National Comprehensive Cancer Network. Clinical practice guidelines in oncology: adult cancer pain. 2011. http://www.nccn.org/professionals/physi cian-gls/f-guidelines.asp-supportive.
33. Davies P, D'Arcy Y. Compact Clinical Guide to Cancer Pain Management: An Evidence-Based Approach for Nurses. Springer Publishing Company; 2013:271-300.
34. Ballantyne JC, Mao J. Opioid therapy for chronic pain. N Engl J Med. 2003;349(20):1943-1953.
35. Chou R, Fanciullo GJ, Fine PG, et al.; American Pain Society-American Academy of Pain Medicine Opioids Guidelines Panel. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10(2):113-130.
36. Lavoie Smith EM, Pang H, Cirrincione C, et al. Effect of duloxetine on pain, function, and quality of life among patients with chemotherapyinduced painful peripheral neuropathy. A randomized clinical trial. JAMA. 2013;309(13):1359-1367.
37. Rao RD, Michalak JC, Sloan JA, et al. Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3). Cancer. 2007;110(9):2110-2118.
38. O'Connor AB, Dworkin RH. Treatment of neuropathic pain: an overview of recent guidelines. Am J Med. 2009;122(suppl 10):S22-S32.
39. Krenzelok EP. The FDA Acetaminophen Advisory Committee Meeting-what is the future of acetaminophen in the United States? The perspective of a committee member. Clin Toxicol (Phila). 2009;47(8):784-789.
40. American Geriatrics Society Panel on Pharmacological Management of Persistent Pain in Older Persons. Pharmacological management of persistent pain in older persons. J Am Geriatr Soc. 2009;57(8):1331-1346.
41. Navarro VJ, Senior JR. Drug-related hepatotoxicity. N Engl J Med. 2006;354(7):731-739.
42. Hawkins C, Hanks GW. The gastroduodenal toxicity of nonsteroidal antiinflammatory drugs: a review of the literature. J Pain Symptom Manage. 2000;20(2):140-151.
43. Hunt RH, Choquette D, Craig BN, et al. Approach to managing musculoskeletal pain: acetaminophen, cyclooxygenase-2 inhibitors, or traditional NSAIDs? Can Fam Physician. 2007;53(7):1177-1184.
44. Zacher J, Altman R, Bellamy N, et al. Topical diclofenac and its role in pain and inflammation: an evidence-based review. Curr Med Res Opin. 2008;24(4):925-950.
45. McCleane G. Topical analgesics. Anesthesiol Clin. 2007;25(4):825-839.
46. Passik SD, Kirsh KL. Chemical coping: The clinical middle ground. In HS Smith & SD Passik (eds), Pain and Chemical Dependency. New York: Oxyford Univeristy Press; 2008:299-302.
47. American Cancer Society. National Cancer Survivorship Resource Center. http://www.cancer.org/treatment/survivorshipduringandaftertreatment/ nationalcancersurvivorshipresourcecenter/index.
48. Nail LM. Long-term persistence of symptoms. Semin Oncol Nurs. 2001;17(4):249-254.
49. Ganz PA. Quality of care and cancer survivorship: the challenge of implementing the Institute of Medicine recommendations. J Oncol Pract. 2009;5(3):101-105.
50. Baehring J, Wollmann G. Neurologic sequelae of cancer therapy. In: Miller K, ed. Medical and Psychosocial Care of the Cancer Survivor. Boston, MA: Jones & Bartlett; 2010:323-339.
51. Wilkes G. Peripheral neuropathy related to chemotherapy. Semin Oncol Nurs. 2007;23(3):162-173.
52. Syrjala K, Martin P, Deeg J, Boeckh M. Medical and psychosocial issues in transplant survivors. Cancer Survivorship. 2007:188-214.
53. Miller K. Medical and Psychosocial Care of the Cancer Survivor. Jones & Bartlett Learning; 2010.